Literature DB >> 16368875

Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation.

Scherise Mitchell1, Asuka Ota, William Foster, Bin Zhang, Zixing Fang, Shilpa Patel, Stanley F Nelson, Steve Horvath, Yibin Wang.   

Abstract

Three major MAP kinase signaling cascades, ERK, p38, and JNK, play significant roles in the development of cardiac hypertrophy and heart failure in response to external stress and neural/hormonal stimuli. To study the specific function of each MAP kinase branch in adult heart, we have generated three transgenic mouse models with cardiac-specific and temporally regulated expression of activated mutants of Ras, MAP kinase kinase (MKK)3, and MKK7, which are selective upstream activators for ERK, p38, and JNK, respectively. Gene expression profiles in transgenic adult hearts were determined using cDNA microarrays at both early (4-7 days) and late (2-4 wk) time points following transgene induction. From this study, we revealed common changes in gene expression among the three models, particularly involving extracellular matrix remodeling. However, distinct expression patterns characteristic for each pathway were also identified in cell signaling, growth, and physiology. In addition, genes with dynamic expression differences between early vs. late stages illustrated primary vs. secondary changes on MAP kinase activation in adult hearts. These results provide an overview to both short-term and long-term effects of MAP kinase activation in heart and support some common as well as unique roles for each MAP kinase cascade in the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16368875     DOI: 10.1152/physiolgenomics.00224.2005

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  18 in total

1.  Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism.

Authors:  Jorge Suarez; Brian T Scott; Jorge A Suarez-Ramirez; Citlalic V Chavira; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-06       Impact factor: 4.249

Review 2.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

3.  Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy.

Authors:  Anna K Paulsson; Sarah Franklin; Scherise A Mitchell-Jordan; Shuxun Ren; Yibin Wang; Thomas M Vondriska
Journal:  J Mol Cell Cardiol       Date:  2010-02-17       Impact factor: 5.000

Review 4.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

Review 5.  Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives.

Authors:  Sabzali Javadov; Sehwan Jang; Bryan Agostini
Journal:  Pharmacol Ther       Date:  2014-06-09       Impact factor: 12.310

Review 6.  Mitogen-activated protein kinase inhibitor regulation of heart function and fibrosis in cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Antoine Muchir; Wei Wu; Howard J Worman
Journal:  Trends Cardiovasc Med       Date:  2010-10       Impact factor: 6.677

7.  MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.

Authors:  John M Streicher; Shuxun Ren; Harvey Herschman; Yibin Wang
Journal:  Circ Res       Date:  2010-03-25       Impact factor: 17.367

8.  Capacity for resolution of Ras-MAPK-initiated early pathogenic myocardial hypertrophy modeled in mice.

Authors:  Bih-Rong Wei; Philip L Martin; Shelley B Hoover; Elizabeth Spehalski; Mia Kumar; Mark J Hoenerhoff; Julian Rozenberg; Charles Vinson; R Mark Simpson
Journal:  Comp Med       Date:  2011-04       Impact factor: 0.982

9.  A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Authors:  Raghu S Nagalingam; Nagalingam R Sundaresan; Mahesh P Gupta; David L Geenen; R John Solaro; Madhu Gupta
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

10.  The serine/threonine-protein kinase/endoribonuclease IRE1α protects the heart against pressure overload-induced heart failure.

Authors:  DeAnna Steiger; Tomohiro Yokota; Jin Li; Shuxun Ren; Susumu Minamisawa; Yibin Wang
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.